The competitive α7nAChR antagonist, α-bungarotoxin, has been shown to reverse α7nAChR-induced protection against β-amyloid in an in vitro model of Alzheimer's disease [28]. The gene discussed is CHRNA7; the disease is early-onset autosomal dominant Alzheimer disease.